|
Title: |
|
Authors:
|
|
Abstract: Background:
Uterine fibroids are among the most common benign gynecologic tumors in women
of reproductive age. Both uterine artery embolization (UAE) and myomectomy are
effective uterus-preserving treatment options. This study aimed to compare
clinical outcomes, complication rates, and patient follow-up results between
UAE and myomectomy performed at
Methods:
This retrospective cohort study included 110 women treated for symptomatic
uterine fibroids between January 2021 and December 2023 at King Saud Medical
City (KSMC) and Qatif Central Hospital (QCH). Eligible patients were aged ≥18
years with fibroids >2 cm and symptomatology such as menorrhagia or pelvic
pain. Data were analyzed using SPSS version 25, with t-tests and Chi-square
tests used for continuous and categorical variables, respectively.
Results:
The mean age was 40 years (range: early 30s–mid-50s). The mean fibroid count
was 2.33 (range: 1–32). Overall, 89% of patients reported symptomatic
improvement, with complication rates below 6%. Myomectomy achieved 100%
improvement with no failures or amenorrhea, whereas UAE resulted in 65%
improvement, 3 failures, 3 amenorrhea cases, and one hysterectomy. Myomectomy
showed significantly better clinical improvement (AOR = 5.70, p = 0.0006).
Younger age and lower fibroid count were also
associated with better outcomes.
Conclusion:
Both UAE and myomectomy are safe and effective uterine-sparing treatments.
Myomectomy remains the gold standard for women desiring fertility or complete
symptom resolution, whereas UAE provides a minimally invasive, lower-risk
alternative for those seeking DOI: http://dx.doi.org/10.51505/ijmshr.2026.10105 |
|
PDF Download |